Navigation Links
New Afatinib (BIBW 2992) Data in Non-Small Cell Lung Cancer Patients Presented at the 2010 ESMO Congress
Date:10/11/2010

RIDGEFIELD, Conn., Oct. 11 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. announced today results from two clinical trials for its investigational cancer compound afatinib* (BIBW 2992) presented at the 35th European Society for Medical Oncology (ESMO) Congress in Milan, Italy.  In the phase IIb/III LUX-Lung 1 study, afatinib tripled the secondary endpoint of progression free survival (PFS) but did not extend the primary endpoint of overall survival (OS) in late-stage patients with non-small cell lung cancer (NSCLC).(1)      

Afatinib is an investigational orally administered irreversible inhibitor of both the epidermal growth factor receptor (EGFR) and human epidermal receptor 2 (HER2) tyrosine kinases.  Afatinib is under development in several solid tumors including NSCLC, breast and head and neck cancer.

The LUX-Lung 1 trial compared afatinib to placebo in over 580 patients with advanced NSCLC who had received chemotherapy and a prior EGFR tyrosine kinase inhibitor (EGFR TKI; gefitinib or erlotinib);(1) results show:

  • Afatinib did not improve OS compared to placebo – 10.78 months vs. 11.96 months, respectively (HR = 1.08, 95% CI 0.86 to 1.35)(1)
  • As a secondary endpoint, afatinib extended PFS three-fold compared to placebo (3.3 months vs. 1.1 months) (HR = 0.38, 95% CI 0.31 to 0.48, p<0.0001).  The improvement in PFS was apparent across all patient subgroups and has been confirmed by independent review(1)
  • At 8 weeks, there was a significantly higher disease control rate (stable disease and tumor shrinkage) in those patients who took afatinib (58%) vs. those taking placebo (19%), which was also independently verified (p<0.0001)(1)
  • Improvement of the lung cancer-related symptoms of cough, dyspnea and pain was observed in the afatinib arm vs. placebo.  In addition, the time to deterioration of cough, individual dyspnea items an
    '/>"/>

SOURCE Boehringer Ingelheim Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Newly Published Phase II Study Shows the Investigational Drug Vandetanib Prolongs Progression-Free Survival in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
2. Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer
3. AstraZeneca Completes Enrollment in First Phase III Study of the Investigational Drug Vandetanib (ZACTIMA)(R) in Non-Small Cell Lung Cancer
4. Exelixis Initiates Phase 1/2 Trial of XL184 in Patients With Non-Small Cell Lung Cancer
5. Peregrine Pharmaceuticals Receives Approval to Conduct a Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer
6. Oral Talactoferrin Alfa Improves Overall Survival in Patients With Refractory Non-Small Cell Lung Cancer: Final Phase 2 Study Results Presented at the 8th Annual Targeted Therapies for the Treatment Of Lung Cancer Meeting
7. Kosan Initiates Phase 2 Trial of Epothilone KOS-1584 in Non-Small Cell Lung Cancer
8. New Data on MAGE-A3 Cancer Immunotherapy Support Potential Novel Options of Treating Non-Small Cell Lung Cancer and Melanoma
9. IDM Pharma Announces Phase 2 Follow-Up Data Showing IDM-2101 is Well Tolerated With Positive Survival Trend in Non-Small Cell Lung Cancer Patients
10. Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer
11. Human Genome Sciences Completes Enrollment in Randomized Phase 2 Trial of HGS-ETR1 in Non-Small Cell Lung Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2015)... JERUSALEM , April 27, 2015 ... successfully completed filing of a Pre-Marketing Notification Application (510k) ... its BRH-A2 Wound Management System. BRH Medical expects feedback ... entering the US market with BRH-A2 following FDA pre-market ... Motti Oderberg , CEO for BRH ...
(Date:4/27/2015)... , April 27, 2015 - ... Process Patent by the State Intellectual Property Office of ... Based on Pooling Technology  - A New Treatment ... (CLI)    - About 20% of Elderly Urban ... in Women is Substantially Higher Than in Men. CLI is ...
(Date:4/26/2015)... April 26, 2015  Ikonopedia announced today that ... system have been selected for use by BelleBridge, ... screening and diagnostic examinations. Ikonopedia will showcase its ... of Breast Imaging,s SBI/ACR Breast Imaging Symposium in ... 2015 (SBI Booth #216). BelleBridge is ...
Breaking Medicine Technology:BRH Medical, Ltd., Announces Filing of a Pre-Market Submission with the US Food and Drug Administration (FDA) for the BRH-A2 Tissue Management System 2Stempeutics Gets Stem Cell Patent in China (Chinese Application Number: CN201080053627) for its Novel Stem Cell Drug 'Stempeucel' 2Stempeutics Gets Stem Cell Patent in China (Chinese Application Number: CN201080053627) for its Novel Stem Cell Drug 'Stempeucel' 3Stempeutics Gets Stem Cell Patent in China (Chinese Application Number: CN201080053627) for its Novel Stem Cell Drug 'Stempeucel' 4Ikonopedia Selected to Provide Breast Imaging Report Generation Capabilities for BelleBridge's Breast Telemedicine Services 2Ikonopedia Selected to Provide Breast Imaging Report Generation Capabilities for BelleBridge's Breast Telemedicine Services 3Ikonopedia Selected to Provide Breast Imaging Report Generation Capabilities for BelleBridge's Breast Telemedicine Services 4
... of human-animal hybrids to generate stem cells WORCESTER, ... Pink Sheets: ACTC) and its collaborators reported today that ... reprogram adult human cells. The research, which appears online ... Stem Cells (Editor-in-Chief: Sir Ian Wilmut; published by ...
... Men who experience erectile dysfunction between the ages of ... disease than men without dysfunction, according to a new Mayo ... have an 80 percent higher risk of heart disease. "The ... says researcher Jennifer St. Sauver, Ph.D. The study was published ...
Cached Medicine Technology:Cloned Human Embryos Successfully Reprogrammed Using Human - But Not Animal - Eggs 2Cloned Human Embryos Successfully Reprogrammed Using Human - But Not Animal - Eggs 3Cloned Human Embryos Successfully Reprogrammed Using Human - But Not Animal - Eggs 4Cloned Human Embryos Successfully Reprogrammed Using Human - But Not Animal - Eggs 5Mayo Clinic Study Finds Younger Men With Erectile Dysfunction at Double Risk of Heart Disease 2Mayo Clinic Study Finds Younger Men With Erectile Dysfunction at Double Risk of Heart Disease 3
(Date:4/27/2015)... Attorney Dan Newlin, of the Law Offices ... clients, took that commitment to a whole new level with ... it easier for existing and potential clients to contact the ... and added value to the firm’s services, #Dan covers Central ... has law offices. , “I knew the pound sign (#) ...
(Date:4/27/2015)... 27, 2015 Texas has saved $433 ... drug offenders to providing drug offenders with addiction treatment, ... on April 8th. Several states, including Massachusetts, are considering ... incarceration. Texas has formed community recovery programs to help ... The Council of State Governments WA, ID, NE, ...
(Date:4/27/2015)... 2015 Climate change predictions are largely ... the number of variables used and the availability of ... water researcher Gerald Pollack, PhD, and Climatologist L.DeWayne Cecil, ... Water® radio show, noted three potential weaknesses that could ... of these individuals dispute that Earth’s climate is changing. ...
(Date:4/27/2015)... Winscribe Professional for Windows Phones ... mobile speech productivity technology, which also includes applications ... , Winscribe has supported mobile dictation ... With the latest enhancement, Winscribe Professional for ... interface in the last ten years. The ...
(Date:4/27/2015)... PREVENT Life Safety, America’s premier provider ... with the addition of an account manager in Houston. ... a growing customer base, Curtis Rice, an experienced sales ... Account Manager. Curtis has been added to the team ... the Houston area and beyond. , Curtis ...
Breaking Medicine News(10 mins):Health News:Dan Newlin Hashtags It With #Dan 2Health News:Texas Saves $443 Million Embracing Justice Reinvestment for Drug Charges 2Health News:Texas Saves $443 Million Embracing Justice Reinvestment for Drug Charges 3Health News:Global warming: Computer weather models flawed report Climatologist, Water Researcher on Sharon Kleyne Hour™ radio show 2Health News:Global warming: Computer weather models flawed report Climatologist, Water Researcher on Sharon Kleyne Hour™ radio show 3Health News:Winscribe Professional Dictation for Smartphones Evolves as Microsoft’s Mobile OS Grows 2Health News:Winscribe Professional Dictation for Smartphones Evolves as Microsoft’s Mobile OS Grows 3Health News:Winscribe Professional Dictation for Smartphones Evolves as Microsoft’s Mobile OS Grows 4Health News:PREVENT Life Safety Services Welcomes Curtis Rice as a New Senior Account Manager in Houston, TX 2
... Bangalore, SUNNYVALE, Calif., Jan. 8 Accuray,Incorporated ... the field of radiosurgery,announced today that Healthcare Global ... for its new oncology center in,Bangalore, India. Upon ... first,CyberKnife System in India, expanding treatment access to ...
... N.J., Jan. 8 Jennifer J. Day, Senior Vice,President ... the,addition of Kenneth A. Sylvia as publisher of Current ... healthcare industry who brings to DHM,30 years of experience ... bases we serve," Day said. DHM is a subsidiary ...
... Affairs highlights large employer,s efforts to ... to treatment, PHILADELPHIA, Jan. 8 Removing ... to remain,on recommended therapies according to a new ... Health Affairs. The study, funded, in part,by GlaxoSmithKline ...
... Too Faced ... Cosmetics and FUZE Beverages, NEW YORK, Jan. 8 ... a lip gloss that keeps you both energized,and beautiful. Yes indeed ... lip gloss on the market to "fuse" beauty and fitness,benefits, this ...
... Centers and free coffee ... give blood, DETROIT, Jan. 8 In honor of ... Cross Donors,Employees and Volunteers in Michigan for two weeks in ... all donors,at any of the participating American Red Cross blood ...
... Medicaid spending slowed for first time since its inception ... The new Medicare prescription drug plan was largely responsible ... 2006, which was double the increase in spending from ... 2006, Medicare spending reached $401.3 billion, an increase from ...
Cached Medicine News:Health News:CyberKnife Radiosurgery Expands to India 2Health News:CyberKnife Radiosurgery Expands to India 3Health News:New Study Indicates Decreasing Prescription Copayments Results in Increased Adherence for Patients with Chronic Diseases 2Health News:New Study Indicates Decreasing Prescription Copayments Results in Increased Adherence for Patients with Chronic Diseases 3Health News:New Study Indicates Decreasing Prescription Copayments Results in Increased Adherence for Patients with Chronic Diseases 4Health News:New Study Indicates Decreasing Prescription Copayments Results in Increased Adherence for Patients with Chronic Diseases 5Health News:NEW! Too Faced FUZE Slenderize Guilt Free Gloss 2Health News:Dunkin' Donuts Celebrates the New Year by Supplying Goodies to Michigan's American Red Cross 2Health News:Medicare Drug Plan Fuels Health-Care Spending 2Health News:Medicare Drug Plan Fuels Health-Care Spending 3
... Studies have proven that the management of ... blood glucose levels is the most effective way ... comprehensive care aimed at maintaining or improving a ... complex and costly. , ,These have been ...
... requires making decisions about insulin dosages and ... decisions are guided by data from blood ... by the patterns that can be seen ... when the data is presented in organized ...
... Pumped Green Photocoagulator - Portable and rugged ... outpatient clinic, and operating room. Built to ... in the most demanding environments, the Novus ... A full line of accessories for ...
The ring maintains the bag tension avoiding the development of posterior capsule pleats. It is also established to compensate the efforts induced during the bag retraction....
Medicine Products: